Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Study Phase : Phase III
Recipient : Nemysis
Deal Size : Undisclosed
Deal Type : Financing
Nemysis Limited Announces Investment by Avia Pharma AB in the Capital of the Company
Details : The financing aims to fund the clinical development of IHAT (iron hydroxide adipate tartrate), which is being evaluated for the treatment of iron deficiency.
Product Name : IHAT
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Undisclosed
March 18, 2025
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Highest Development Status : Phase III
Recipient : Nemysis
Deal Size : Undisclosed
Deal Type : Financing